H. Kroll

1.4k total citations
37 papers, 980 citations indexed

About

H. Kroll is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, H. Kroll has authored 37 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 17 papers in Genetics and 11 papers in Surgery. Recurrent topics in H. Kroll's work include Platelet Disorders and Treatments (26 papers), Blood groups and transfusion (18 papers) and Blood disorders and treatments (17 papers). H. Kroll is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Blood groups and transfusion (18 papers) and Blood disorders and treatments (17 papers). H. Kroll collaborates with scholars based in Germany, United States and Switzerland. H. Kroll's co-authors include Sentot Santoso, V. Kiefel, Andreas Greinacher, Petra Eichler, Thomas J. Kunicki, Werner Haberbosch, Andreas Gardemann, C. Mueller‐Eckhardt, C Mueller-Eckhardt and R Kalb and has published in prestigious journals such as Journal of Biological Chemistry, Blood and British Journal of Haematology.

In The Last Decade

H. Kroll

35 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Kroll Germany 16 653 460 275 201 183 37 980
M. J. Mant Canada 15 337 0.5× 146 0.3× 167 0.6× 40 0.2× 129 0.7× 25 758
Paul Kaywin United States 8 297 0.5× 190 0.4× 100 0.4× 76 0.4× 78 0.4× 10 505
E. Törnebohm Sweden 12 256 0.4× 238 0.5× 453 1.6× 30 0.1× 366 2.0× 17 656
Silvia Vettore Italy 17 475 0.7× 109 0.2× 103 0.4× 11 0.1× 114 0.6× 39 719
Werner Feuerer Germany 9 197 0.3× 330 0.7× 185 0.7× 37 0.2× 566 3.1× 12 837
James R. Wilentz United States 13 66 0.1× 615 1.3× 135 0.5× 30 0.1× 553 3.0× 28 942
Sheryl L. Carr United States 12 226 0.3× 208 0.5× 119 0.4× 10 0.0× 168 0.9× 23 545
R. J. Lennane United Kingdom 6 192 0.3× 313 0.7× 136 0.5× 16 0.1× 499 2.7× 8 914
Gabrielle J. Pennings Australia 14 201 0.3× 133 0.3× 110 0.4× 7 0.0× 224 1.2× 27 559
Yolanda Mira Spain 16 482 0.7× 116 0.3× 388 1.4× 8 0.0× 210 1.1× 42 761

Countries citing papers authored by H. Kroll

Since Specialization
Citations

This map shows the geographic impact of H. Kroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kroll more than expected).

Fields of papers citing papers by H. Kroll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kroll. The network helps show where H. Kroll may publish in the future.

Co-authorship network of co-authors of H. Kroll

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kroll. A scholar is included among the top collaborators of H. Kroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kroll. H. Kroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sachs, Ulrich J., V. Kiefel, H. Kroll, Gregor Bein, & Sentot Santoso. (2012). Report on the 15th International Society of Blood Transfusion platelet immunology workshop. Vox Sanguinis. 103(4). 343–351. 16 indexed citations
2.
Schindewolf, Marc, H. Kroll, H. Ackermann, et al.. (2010). Heparin‐induced non‐necrotizing skin lesions: rarely associated with heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 8(7). 1486–1491. 34 indexed citations
3.
Kroll, H., Bruno P. Soares, David Saloner, William P. Dillon, & Max Wintermark. (2009). Perfusion-CT of developmental venous anomalies: typical and atypical hemodynamic patterns. Journal of Neuroradiology. 37(4). 239–242. 18 indexed citations
4.
Schindewolf, Marc, Manfred Wolter, H. Kroll, et al.. (2009). Incidence and causes of heparin-induced skin lesions. Canadian Medical Association Journal. 181(8). 477–481. 59 indexed citations
5.
Ullrich, Oliver, Christian Thiel, Katrin Paulsen, et al.. (2009). Adhesion molecule expression and cell cycle control in cells of the immune system are sensitive to altered gravity. Cell Communication and Signaling. 7(S1). 1 indexed citations
6.
Schindewolf, Marc, Ralf J. Ludwig, H. Kroll, Wolf‐­Henning Boehncke, & Edelgard Lindhoff‐Last. (2007). CUTANEOUS DELAYED-TYPE IV-HYPERSENSITIVITY REACTION (DTH) TO HEPARIN AND HEPARIN-INDUCED THROMBOCYTOPENIA TYPE II (HIT) - IS THERE AN ASSOCIATION ?. Journal of Thrombosis and Haemostasis. 5. P–T. 1 indexed citations
7.
Greinacher, Andreas, et al.. (2006). Empfehlungen zur Thrombozytentransfusion. DMW - Deutsche Medizinische Wochenschrift. 131(47). 2675–2679. 14 indexed citations
8.
Zenz, Werner, et al.. (2001). Danaparoid sodium (Orgaran®) in four children with heparin‐induced thrombocytopenia type II. Acta Paediatrica. 90(7). 765–771. 25 indexed citations
9.
Kroll, H., et al.. (2001). Workshop Report on the Genotyping of Blood Cell Alloantigens. Transfusion Medicine. 11(3). 211–219. 24 indexed citations
10.
Eichler, Petra, et al.. (2001). A Comparison of Danaparoid and Lepirudin in Heparin-induced Thrombocytopenia. Thrombosis and Haemostasis. 85(6). 950–957. 133 indexed citations
11.
Birchall, Janet, M. F. Murphy, C. Kaplan, & H. Kroll. (2000). European study of the antenatal management of fetomaternal alloimmune thrombocytopenia (FMAIT). Transfusion Medicine. 10(4). 328–328. 2 indexed citations
12.
Kiefel, V., C. D. W. König, H. Kroll, & Sentot Santoso. (2000). Platelet antibodies in transfused patients. Transfusion Medicine. 10(4). 327–327. 1 indexed citations
13.
Eichler, Petra, U. Budde, Sylvia Haas, et al.. (1999). First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA. Thrombosis and Haemostasis. 81(4). 625–629. 127 indexed citations
14.
Kiefel, V., Erik Freitag, H. Kroll, Sentot Santoso, & C. Mueller‐Eckhardt. (1996). Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins IIb/IIIa and Ib/IX in patients with thrombocytopenia. Annals of Hematology. 72(4). 280–285. 56 indexed citations
15.
Kalb, R, et al.. (1995). Genomic RFLP typing of human platelet alloantigens Zw(PlA), Ko, Bak and Br (HPA‐1, 2, 3, 5). British Journal of Haematology. 89(1). 169–176. 66 indexed citations
16.
Kiefel, V., M Vicariot, Yves Giovangrandi, et al.. (1995). Alloimmunization against ly, a Low‐Frequency Antigen on Platelet Glycoprotein Ib/IX as a Cause of Severe Neonatal Alloimmune Thrombocytopenic Purpura. Vox Sanguinis. 69(3). 250–254. 15 indexed citations
17.
Kroll, H., V. Kiefel, G. Giers, et al.. (1994). Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia. Transfusion Medicine. 4(4). 293–296. 57 indexed citations
18.
Santoso, Sentot, R Kalb, H. Kroll, et al.. (1994). A point mutation leads to an unpaired cysteine residue and a molecular weight polymorphism of a functional platelet beta 3 integrin subunit. The Sra alloantigen system of GPIIIa.. Journal of Biological Chemistry. 269(11). 8439–8444. 52 indexed citations
19.
Kroll, H., V. Kiefel, & C Mueller-Eckhardt. (1992). [Clinical and serologic studies in 34 patients with post-transfusion purpura].. PubMed. 30. 403–7. 6 indexed citations
20.
Kroll, H.. (1958). The cervical syndrome; an irritative process of cervical nerve roots with many and varied symptoms.. PubMed. 59(9). 385–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. J. Mant Breakdown of academic impact, for papers by Paul Kaywin Breakdown of academic impact, for papers by E. Törnebohm Breakdown of academic impact, for papers by Silvia Vettore Breakdown of academic impact, for papers by Werner Feuerer Breakdown of academic impact, for papers by James R. Wilentz Breakdown of academic impact, for papers by Sheryl L. Carr Breakdown of academic impact, for papers by R. J. Lennane Breakdown of academic impact, for papers by Gabrielle J. Pennings Breakdown of academic impact, for papers by Yolanda Mira
Rankless by CCL
2026